Clinical Evidence ClosureFast™ RFA System
Building long-term evidence with high clinical standards
Go Gap-free For Patented Performance
The ClosureFast™ procedure, with its patented overlap design, is the only RFA procedure with published long-term clinical data demonstrating safety and efficacy, with a 91.9% closure rate at 5 years.1,2
- 250+ published clinical studies and articles3
- Over 2 million patients have been treated with the ClosureFast™ procedure in over 100 countries around the world.4
Individual results may vary. Images courtesy of Jonathan Calure, M.D., of Maryland Vein Professionals.
5-year Study Results
91.9% closure rate at 5 years1
94.9% reflux-free rate at 5 years1
72% improvement in VCSS scores at 5 years5
Additional Resources
Related Pages
Connect with us
Connect with a Medtronic representative and receive updates and ongoing information.
Contact us
ClosureFast™ Radiofrequency Ablation System
Learn MoreReferences
1
Proebstle TM, Alm BJ, Göckeritz O, et al. Five-year results from the prospective European multicentre cohort study on radiofrequency segmental thermal ablation for incompetent great saphenous veins. Br J Surg. February 2015;102(3):212-218.
2
ClosureFast and ClosureFast RFS Patents. Medtronic data on file, 2022.
3
Medtronic ClosureFast Procedure Publications. Medtronic data on file, 2019.
4
ClosureFast Procedures. Medtronic data on file, 2019.
5
Morrison N, Gibson K, Vasquez M, et al. Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. November 2020;8(6):978-989.